Navigation Links
A dry AMD treatment?; some long-term diabetics escape PDR
Date:10/17/2010

CHICAGOAt the American Academy of Ophthalmology (AAO) Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting today, researchers report progress on two top eye disease challenges: treating advanced "dry" age-related macular degeneration, and preventing blindness in people with diabetes. The Joint Meeting is in session October 16 through 19 at McCormick Place, Chicago. The AAO-MEACO meeting is the world's largest, most comprehensive ophthalmic education conference.

Proven Arthritis Drug Shows Promise versus Dry AMD:

While ophthalmologists can turn to several medications for patients with vision-threatening "wet" age-related macular degeneration (AMD), there are no effective treatments for advanced "dry" AMD, the more common form. Today a research group led by Jason S. Slakter, MD, New York University School of Medicine, reports on a phase-two clinical trial of fenretinide, a synthetic derivative of vitamin A. Risk of developing wet AMD decreased almost two-fold in dry AMD patients who took the medication. Geographic atrophy (GA) lesion growth was also reduced in the fenretinide group. This reduced growth correlated with lowered blood levels of the biomarker retinol binding protein (RBP)an indication that fenretinide was working. Patients whose RBP decreased 60 percent or more also had the most significant reductions in lesion growth. GA lesions degrade the area of the eye called the retinal pigment epithelium (RPE), which can result in significant vision loss.

Advanced AMD, in either wet or dry form, can destroy the detailed, central vision we need to recognize faces, read, drive, and enjoy daily life. It is a major cause of vision loss in the United States. In the advanced wet form abnormal new blood vessels develop under the retina, then bleed or leak fluid and form scars. Advanced dry AMD sometimes abruptly converts to the wet form.

Fenretinide works on three key AMD disease mechanisms: it has strong ant
'/>"/>

Contact: Mary Wade
mwade@aao.org
510-725-5677
American Academy of Ophthalmology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Battlefield camaraderie yields long-term dividends for veterans, study finds
2. Newer cornea transplant surgery shows short- and long-term promise
3. Proton beam therapy shows encouraging long-term outcome for patients with locally advanced sinonasal cancers
4. Clinton Bush Haiti Fund Awards International Medical Corps $500,000 for Emergency Medical Care and Long-Term Rebuilding
5. Quantity vs. quality: Long-term use of bone-building osteoporosis drugs
6. Options to Integrate Health and Long-Term Care for Dual Eligibles
7. Long-Term Use of Osteoporosis Drugs Linked to Fractures
8. Plaque on CT scan is strong predictor of heart disease, worse long-term outcomes
9. Increased radiation dose does not increase long-term side effects for prostate cancer patients
10. Health Care Reform Bill Will Also Improve Long-Term Care
11. Long-Term Breast-Feeding Tied to More Aggressive Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... The report, “Blowing Agents Market by ... and Forecasts to 2019” defines and segments the ... of the global consumption volume and value. , ... 39 figures spread through 226 Pages and in-depth ... , Blowing agents are highly utilized materials as ...
(Date:7/28/2014)... for patients with one of the UK,s most common ... Chronic obstructive pulmonary disease (COPD) is the name for ... to long-term damage to the lungs. Often linked ... of all hospital admissions in the UK, with a ... they are discharged. , A team of ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Drorit Silverman, ... unveiled new plans to raise investment capital through her ... fitness concept in the United States. , According to ... of 24/7 fitness centers provide a great window of ... rapidly expanding space. In addition to this, Silverman looks ...
(Date:7/28/2014)... -- Researchers from The University of Texas Health Science Center ... have identified a combination of pills that cures 9 of ... sofosbuvir and simeprevir, with or without ribavirin, cured 93 percent ... patients, according to the study published today in The ... U.S. , Eric Lawitz, M.D., clinical professor in the ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 The North America ... & antioxidants market in North America with analysis and forecast ... $539.9 million in 2012 to $812.7 million by 2018, at ... through the TOC of the North America Carotenoids & Antioxidants ... provided. It also provides a glimpse of the segmentation in ...
Breaking Medicine News(10 mins):Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 3Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 4Health News:New research to tackle treatment for lung disease 2Health News:New research to tackle treatment for lung disease 3Health News:Pro Bodybuilder Drorit Silverman Confirms Plans to Raise Money for Investment in the Popular 24/7 Fitness Concept 2Health News:New pill regimens published in The Lancet cure hardest-to-treat hepatitis C patients 2Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 4
... of Pharmaceutical Marketing Industry Due to New PhRMA ... 6 Pharmaceutical marketers are taking on the ... Systems, a unique marketing company whose integrated engagement ... the sector. In the past two years the ...
... A survey recently conducted by the Society of ... Compliance Association (HCCA) reveals that the declining economy may ... in business. In addition, this increased risk is ... risks are expected to at best hold steady, if ...
... /PRNewswire/ -- Akerman Senterfitt, one of the ... top 100 firms in the U.S., today announced that ... the auspices of the American Health Lawyers Association (AHLA) ... and issues concerning privilege and confidentiality. The live audiocast ...
... POINT, N.Y., Jan. 6 Akrimax Pharmaceuticals, LLC ... of pharmaceutical products for a global company beginning ... partners in a competitive process.Akrimax President Alan L. ... to acquire the Rouses Point facility which possesses ...
... KENILWORTH, N.J., Jan. 6 Schering-Plough Corporation (NYSE: ... results for the 2008 fourth quarter and full year on ... that day, Schering-Plough will conduct a conference call to review ... Fred Hassan, Schering-Plough,s chairman and CEO, and other members of ...
... for expanding role of patient flow automation PITTSBURGH, Jan. ... its clients, now more than 700 hospitals, solve their ... to increase capacity and improve patient flow is now ... have postponed building and expansion plans because of the ...
Cached Medicine News:Health News:Kyp Systems Takes on the Challenge of New Pharmaceutical Marketing Guidelines 2Health News:Kyp Systems Takes on the Challenge of New Pharmaceutical Marketing Guidelines 3Health News:Legal and Ethical Violations Risks Seen Rising, But Not Resources to Control the Risk 2Health News:Legal and Ethical Violations Risks Seen Rising, But Not Resources to Control the Risk 3Health News:Akerman Senterfitt Hosts National Panel Discussion on Patient Safety Organizations 2Health News:Akerman Senterfitt Hosts National Panel Discussion on Patient Safety Organizations 3Health News:Akrimax Pharmaceuticals Announces Manufacturing Partnership 2Health News:Schering-Plough Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Year Earnings 2Health News:TeleTracking Technologies to Focus on Growth 2Health News:TeleTracking Technologies to Focus on Growth 3
(Date:7/28/2014)... 28, 2014  A prospective study conducted by ... has validated the performance of VolparaDensity breast ... associated volumetrically assessed breast density measurements to breast ... & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the article, "Automated ... widespread breast cancer risk assessment," was authored by ...
(Date:7/28/2014)... , July 28, 2014  Syneron Medical Ltd. (NASDAQ: ... company, announced today that its new PicoWay® device has ... types and colors and pigmented lesions on any skin ... device, with 532nm and 1064nm wavelengths, which utilizes Syneron,s ... using pulses which are trillionths of a second, known ...
(Date:7/28/2014)... ResMed (NYSE: RMD ), innovatore e pioniere ... respiratori del sonno (SDB) e altre patologie croniche del ... il produttore Taiwanese di dispositivi medicali, APEX Medical Corp. ... in testa, che violano i brevetti, utilizzate con l,APEX ... Corte Regionale Distrettuale di Monaco , ...
Breaking Medicine Technology:Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2
... The Premier 12 Holter Analysis Kit incorporates ... Dispersion with other powerful DMS Holter analysis ... TWA analysis possible in less than 10 ... TWA, for visual verification and validation. The ...
Velcro® Tracheostomy tube holders are available in Adult, pediatric, and infant sizes....
... be more comfortable, and you will too., ... secure and to avoid the knotty problems ... twill ties, consider the Dale® Tracheostomy Tube ... the narrow fastener tabs of the Dale® ...
... more comfortable, and you will too., ... and to avoid the knotty problems associated ... ties, consider the Dale® Tracheostomy Tube Holder. ... narrow fastener tabs of the Dale® Tracheostomy ...
Medicine Products: